Feb 25, 2021
Milestone Pharmaceuticals to Present at Upcoming Investor Conferences
Nov 23, 2020
Milestone Pharmaceuticals to Present at Upcoming Investor Conferences
Nov 18, 2020
Milestone Pharmaceuticals Announces First Patient Enrolled in RAPID, a Pivotal Phase 3 Study of Etripamil in PSVT
Nov 13, 2020
Milestone Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Clinical and Corporate Update
Nov 11, 2020
Milestone Pharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference
Oct 23, 2020
Milestone Pharmaceuticals Announces Pricing of a Public Offering of $45 Million of Common Shares and Pre-Funded Warrants
Sep 22, 2020
Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments
Sep 08, 2020
Milestone Pharmaceuticals to Present at Upcoming Investor Conferences
Aug 12, 2020
Milestone Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Clinical and Corporate Update
Aug 06, 2020
Milestone Pharmaceuticals to Present at the Canaccord Genuity 40th Annual Growth Conference
Jul 23, 2020
Milestone Pharmaceuticals Announces Regulatory Guidance and Updated Clinical Development Plan for Etripamil in PSVT
Jul 23, 2020
Milestone Pharmaceuticals Announces $25 Million Private Placement
May 14, 2020
Milestone Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Clinical and Corporate Update
Mar 23, 2020
Milestone Pharmaceuticals Announces Topline Results from First-of-its-kind Phase 3 NODE-301 Trial of Etripamil for At-home Acute PSVT Treatment
Mar 06, 2020
Milestone Pharmaceuticals Reports Fourth Quarter and Year-end 2019 Financial Results and Provides Clinical and Corporate Update
Nov 14, 2019
Milestone Pharmaceuticals to Present at Upcoming Investor Conferences
Nov 13, 2019
Milestone Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Clinical and Corporate Update
Oct 03, 2019
Milestone Pharmaceuticals Announces First Patient Enrolled in NODE-303 Open-label Safety Study of Etripamil in PSVT
Sep 10, 2019
Milestone Pharmaceuticals Announces Appointment of Amit Hasija as Chief Financial Officer and Executive Vice President of Corporate Development
Aug 29, 2019
Milestone Pharmaceuticals to Participate in Upcoming Investor Conferences